BOZZINI, Claudia
 Distribuzione geografica
Continente #
EU - Europa 2.348
NA - Nord America 2.240
AS - Asia 1.210
SA - Sud America 153
AF - Africa 14
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.970
Nazione #
US - Stati Uniti d'America 2.207
RU - Federazione Russa 948
GB - Regno Unito 561
SG - Singapore 465
CN - Cina 419
SE - Svezia 154
FI - Finlandia 152
DE - Germania 140
BR - Brasile 124
FR - Francia 120
HK - Hong Kong 108
IE - Irlanda 105
IT - Italia 64
VN - Vietnam 60
KR - Corea 57
NL - Olanda 39
UA - Ucraina 27
CA - Canada 19
TR - Turchia 19
IN - India 16
BE - Belgio 13
JP - Giappone 12
AR - Argentina 11
ID - Indonesia 11
BD - Bangladesh 10
MX - Messico 9
IL - Israele 7
PL - Polonia 6
AT - Austria 5
ES - Italia 5
ZA - Sudafrica 5
AZ - Azerbaigian 3
CL - Cile 3
EC - Ecuador 3
PK - Pakistan 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CO - Colombia 2
EG - Egitto 2
IQ - Iraq 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
SA - Arabia Saudita 2
TG - Togo 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
HN - Honduras 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MW - Malawi 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
SR - Suriname 1
TN - Tunisia 1
Totale 5.970
Città #
Southend 477
Jacksonville 340
Moscow 337
Chandler 287
Singapore 225
Woodbridge 181
Ashburn 179
Ann Arbor 161
Dallas 144
Houston 112
Hong Kong 108
Dublin 105
New York 70
Helsinki 59
Los Angeles 56
Munich 54
Beijing 41
Lawrence 41
Princeton 41
Lancaster 39
Boardman 37
Nanjing 36
Wilmington 34
Ho Chi Minh City 25
Jinan 25
Tianjin 25
The Dalles 24
Shenyang 20
Zhengzhou 19
Turku 18
Buffalo 17
Santa Clara 17
São Paulo 17
Falkenstein 16
Milan 16
Changsha 14
Hebei 14
Nanchang 14
Brussels 13
Hanoi 13
Seoul 13
Denver 12
Jiaxing 12
Sindelfingen 12
Guangzhou 11
Redondo Beach 11
Tokyo 11
Norwalk 10
San Francisco 10
Seattle 10
Hangzhou 9
Verona 9
Boston 8
Columbus 8
Fuzhou 8
Montreal 7
Rio de Janeiro 7
Stockholm 7
Taiyuan 7
Toronto 7
Atlanta 6
Lanzhou 6
Mestre 6
Warsaw 6
Ankara 5
Dongguan 5
Haikou 5
Mexico City 5
Ningbo 5
Cagliari 4
Kochi 4
London 4
Perugia 4
Poplar 4
San Mateo 4
Vienna 4
Washington 4
Amsterdam 3
Baku 3
Brasília 3
Brooklyn 3
Campinas 3
Chicago 3
Clearwater 3
Fairfield 3
Fortaleza 3
Jakarta 3
Kent 3
Orem 3
Phoenix 3
Porto Alegre 3
Rome 3
Secaucus 3
Shijiazhuang 3
St Louis 3
Topeka 3
Anyang 2
Augusta 2
Baghdad 2
Bangalore 2
Totale 3.806
Nome #
Novel serum paraoxonase activity assays are associated with coronary artery disease 191
Biochemical and genetic markers of iron status and the risk of coronary disease 178
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 171
Clinical and pathological findings in hemochromatosis type 3 due to a novel mutation in transferin receptor 2 gene 169
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 166
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 166
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 164
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 161
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 157
Clinical heterogeneity of acquired hemophilia A: a description of 4 cases. 156
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 154
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 150
A new mutation in transferrin receptor 2 gene in hemochromatosis type 3 150
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 150
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 150
Determinants of serum ferritin in the metabolic syndrome. 149
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 149
Determinants of serum ferritin and prevalence of iron overload in the Metabolic (Insulin Resistance). 148
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 147
Prevalence of body iron excess in the metabolic syndrome. 146
Interaction between PON 2 polymorphism Ser-Cys and smoking as a determinant of myocardial infarction risk 145
Clinical,biochemical and molecular findings in a series of families with hereditary hyperferritinemia cataract syndrome 145
Two new highly polymorphic markers in the 3’UTR region of the PLA2G7 gene 142
BIOCHEMICAL AND GENETIC MARKERS OF IRON STATUS AND RISK OF CORONARY ARTERY DISEASE: AN ANGIOGRAPHIC-BASED STUDY. 140
A new mutation in the trnsferrin receptor 2 gene in hemochromatosis type 3 139
CLINICAL AND HISTOPATHOLOGICAL FINDINGS IN A FAMILY WITH HEMOCROMATOSIS TYPE 3, CARRING A NEW MUTATION IN TRANSFERRIN RECEPTOR 2 GENE 138
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 134
Met-Leu and Gln-Arg PON 1 polymorphisms and mortality after coronary artery by-pass grafing surgery. 128
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 123
Prevalence of hereditary hyperferritinemia-catarat siyndrome in blood donors and in patients with cataract 119
Blunted hepcidin response to oral iron challenge in BFE-related hemochromatosis 118
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 118
Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease 113
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 111
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 110
Influence of the polymorphism in the factor VII gene promoter on Factor VII circulating levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 109
Molecular pathology of hereditary hemochromatosis 108
Increase arachidonic/linoleic acid ratio and a polygenic model of desaturases polymorphism are associated with increase risk of coronary artery disease 103
Polymorphism in the factor VII gene promoter (-323°1°2 and -402 GA) and the risk of myocardial infarction in patients with advance coronary atherosclerosis 93
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 89
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 86
Prevalence of hereditary hyperferritinemia-cataract syndrome in blood donors and in patients with cataract. 82
A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies 78
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 76
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 68
Totale 5.987
Categoria #
all - tutte 18.545
article - articoli 8.824
book - libri 0
conference - conferenze 9.387
curatela - curatele 0
other - altro 334
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021169 0 0 0 0 0 40 5 44 40 2 37 1
2021/2022296 26 70 3 33 18 9 4 18 6 13 28 68
2022/2023803 47 84 74 143 97 179 5 36 95 10 15 18
2023/2024411 8 29 27 44 42 77 9 34 5 18 56 62
2024/2025922 49 74 71 156 32 40 28 17 80 45 93 237
2025/20261.862 199 152 148 484 827 52 0 0 0 0 0 0
Totale 5.987